Patients have selected Dr. Cohen for the Patients' Choice Award for 2009;
a Patient Favorite for the second year in a row!

Lawrence Cohen, M.D.

Lawrence Cohen, MD, is currently an Associate Clinical Professor of Medicine at The Mount Sinai School of Medicine. He graduated from Hahnemann Medical College with highest honors and completed his medical residency and fellowship training at The Mount Sinai Hospital.

Dr. Cohen’s primary research focus is gastrointestinal endoscopy and he lectures throughout the world on subjects ranging from colonoscopy and colorectal cancer screening to endoscopic sedation. He has authored more than 150 book chapters, articles and abstracts and serves on the editorial board or as a scientific reviewer for seven journals. His contributions to gastroenterology and expertise in the field have been recognized by his peers who selected him to be listed in Best Doctors in America, America’s Best Gastroenterologists and Top Doctors in New York.

Office Location(s):

311 East 79th St.
Suite 2A
New York , New York 10075

Location Phone: (212) 996-6633
Location Fax: (212) 996-6677

Accepting new patients:
I am accepting new patients.

Publications

Peer-Review Original Contributions:

1. Chang FN, Cohen LB, et al. Purification and properties of a ribosomal protein from Escherichia coli Q13. Biochemistry 14:4994-7, 1975.

2. Cohen LB, Korsten MA, et al. Bacteremia following endoscopic injection sclerosis. Gastrointestinal Endoscopy 29:198-200, 1983.

3. Cohen LB, Simon C, Korsten MA, et al. Esophageal motility and symptoms after endoscopic injection sclerotherapy. Digestive Diseases and Science 30:29-32, 1985.

4. Cohen LB, Ambinder EP, Wolke AM, et al. The role of plasmapheresis in primary biliary cirrhosis. Gut 26:291-4, 1985.

5. Sachar DB, Smith J, Chan S, Cohen LB, Lichtiger S. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 8:647-650, 1986.

6. Aisenberg J, Cohen LB, Lewis BS. Marked endoscopic gastrostomy tubes permit one-pass Ponsky technique. Gastrointestinal Endosc 78:552-3, 1991.

7. Johnson DA, Ganz R, Aisenberg J, Cohen LB, Deviere J, Foley R, et al. Endoscopic, deep mural implantation of enteryx for the treatment of GERD :6 month follow-up of a multi-center trial. Am J Gastroenterol 98:250-258, 2003

8. Johnson DA, Ganz R, Aisenberg J, Cohen LB, Deviere J, Foley R, et al. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol 98:1921-30, 2003.

9. Cohen LB, Dubovsky AN, Aisenberg J, Miller KM. Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc 58:725-732, 2003.

10. Cohen LB, Hightower CD, Wood DA, Aisenberg J, Miller KM. Moderate-level sedation during endoscopy: A prospective study using low-dose propofol, meperidine/fentanyl and midazolam. Gastrointest Endosc 59:795-803, 2004.

11. Cohen LB, Johnson DA, Ganz RA, Aisenberg J, Devière J, Foley TR, et al. Enteryx® Implantation for GERD: Expanded Multicenter Trial Results and Interim Post-Market Follow-Up to 24 Months. Gastrointest Endosc, 2005;61:650-8.

12. Aisenberg J, Brill JV, Ladabaum U, Cohen LB. Sedation for Gastrointestinal Endoscopy: New Practice, Different Economics. Am J Gastroenterol 2005; 100:996-1000.

13. Cohen LB, Wecsler JS, Gaentano JN, Benson AA, Miller KM, Durkalski V, et. al. Endoscopic sedation in the united states: results from a nationwide survey. Am J Gastroenterol 2006;101:967-974.

14. Benson AA, Cohen LB, Waye JD, et. al. Endoscopic sedation in developing and developed countries. Gut and Liver, 2008; 2:105-112.

15. Aisenberg A, Cohen LB, Piorkowski JD. Propofol use under the direction of trained gastroenterologists – analysis of the medicolegal implications. Am J Gastroenterol. 2007;101:707-713.

16. Lichtenstein, GR, Cohen LB, Uribarri J. Bowel preparation for colonoscopy: importance of adequate hydration. Aliment Pharmacol and Therapeut. 2007; 26: 633-641.

17. Johanson JF, Popp JW, Cohen LB, Lottes SR, Forbes WP, Rose M and Carter E. A Randomized, Multicenter Study Comparing the Safety and Efficacy of Sodium Phosphate Tablets to 2L Polyethylene Glycol Solution Plus Bisacodyl Tablets for Colon Cleansing. Am J Gastroenterol. 2007;102:2238-46.

18. Cohen LB, DeLegge MH, Aisenberg, J, Brill JV, Inadomi JM, Kochman, ML, et al. AGA Institute Review on Endoscopic Sedation. Gastroenterology 2007; 133: 675-701.

19. Cohen L.B. A Randomized, Double-Blind, Dose-Response Study of Fospropofol Disodium for Moderate Sedation during Colonoscopy. Aliment Pharmacol Ther, 2008; 27:597-608.

20. Desai J, Sanyal S, Goo T, Benson A, Bodian C, Miller KM, Cohen LB, et al. How Effective is Omeprazole 20 mg Daily for Primary Prevention of Adverse Gastroduodenal Effects from Short-term Use of Non-Steroidal Anti-Inflammatory Drugs by Healthy Subjects? A Randomized, Double-Blind, Placebo-Controlled Study. Dig Dis Sci 2008; 53:2059-65.

21. Shike M, Fireman Z, Eliakim R, Segol O, Sloyer A, Cohen LB, et. al. The Sightline CS System For A Disposable, Power Assisted, Non-Fiber-Optic Colonoscopy. Gastrointest Endosc, 2008;68:701-710.

22. Cohen, LB. Production pressure in endoscopy. Balancing quantity and quality. Gastroenterology, 2008; 135: 1842-4.

23. Cohen LB, Cattau E, Goetsch CA, Shah A, Weber JR, Rex DR. A Randomized, Double-blind, Phase 3 Study of Fospropofol Disodium for Sedation during Colonoscopy. J Clin Gastroenterol. Submitted for publication, 2009.

24. Fockens P, Cohen LB, Edmundowicz S, Binmoeller K, Rothstein, R, Smith D, et.al. Prospective Randomized Controlled Trial of an Injectable Esophageal Prosthesis versus Sham Procedure for Endoscopic Treatment of GERD. Aliment Pharmacol Therap. Submitted for publication, 2009.

25. Rex DK, Deenadaylu VP, Eid, E, Walker JA, Sandhu K, Clarke AC, Hillman LC, Horiuchi A, Cohen LB, et.al. Endoscopist-directed administration of propofol: a world-wide safety experience. Gastroenterology. In press. 2009.

26. Dikman A, Sanyal S, von Althann, C, Desai J, Bodian C, Brooks A, Bamji N, Cohen LB, et.al. A randomized, placebo-controlled study of the effect of naproxen, aspirin, celecoxib, or clopidogrel on gastroduodenal healing. Aliment Pharmacol Therap 2009; 29:781-791.

27. Desai JC, Goo T, Fukata M, Sanyal S, Dikman A, Miller, K, Cohen LB, et.al. NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression. Aliment Pharmacol Therap 2009;71-81, 2009.

28. Vargo JJ, Cohen LB, Rex DK. Position Statement: Non-anesthesiologist administration of propofol for gastrointestinal endoscopy. To be published simultaneously in Gastroenterology, Am J Gastroenterol, Gastrointest Endosc, and Hepatology, 2009.

Other Peer-Reviewed Publications:

1. Cohen LB, Rubin KP, Waye JD. Duodenal ulcerations following monooctanoin therapy. Gastrointestinal Endoscopy 30:49, 1984.

2. Cohen LB, Field SM, Sachar DB. Superior mesenteric artery syndrome: the disease that isn’t, or is it? J Clin Gastroenterology. 7:113-116, 1985.

3. Heimann TM, Cohen LB, Bolnick K, et al. Villous polyposis of the ileum: a case report. Am J Gastroenterology. 80:983-5, 1985.

4. Sharon M, Puente G, Cohen LB. Phenazopyridine (pyridium) poisoning: possible toxicity of methylene blue administration in renal failure. Mount Sinai J Med 53:280-282, 1986.

5. Kralewski T, Cohen LB. Choriocarcinoma of the stomach. A case report and review of the literature. Am J Gastroenterology 83:1172-75, 1988.6. Luppescu NE, Cohen LB. Transient obstruction of the esophagus following pneumatic dilation. J Clin Gastroenterol 11:64-8, 1989.

7. Bach N, Schultz BL, Cohen LB, et al. Amiodarone hepatotoxicity: progression from steatosis to cirrhosis. Mt Sinai J Med

8. Fleshner PR, Cohen LB, Sicular A, Hirschhorn K, Matta RJ. Fanconi's anemia and esophageal carcinoma. Gullet 3:60-63, 1993.

9. Harris MT, Tenembaum M, Drew M and Cohen LB. Esophageal obstruction complicating malignant mesothelioma: palliation with colon interposition. Diseases of the Esophagus 2: 212-214, 1994.

10. Cohen LB. Fospropofol disodium: a discussion with a key opinion leader. Rev Gastroenterol Disord. 2008;8:213-16.

11. Doshi AH, Aw J, Costa F, Cohen LB, Som PM. Cervical Tracheal Compression in a Patient with Achalasia: An Uncommon Event. Am J Neuroradiol in press.

12. Cohen LB. “Nurse-Administered Propofol Sedation for Upper Endoscopic Ultrasonography: Not yet ready for prime time.” Nature Clinical Practice Gastroenterology and Hepatology 2009;6:76-77.

Invited Contributions:

1. Cohen LB. Clinical applications of gastrointestinal motility tests. Mount Sinai J Med 51:620-4, 1984.

2. Cohen LB, Waye JD. Oral electrolyte solutions for colonic lavage before colonoscopy or barium enema. Medical Letter 27: 39-40, 1985.

3. Cohen LB. A twelve part series of endoscopic findings on flexible sigmoidoscopy. Primary care and Cancer, 1985-6.

4. Cohen LB. The patient with dysphagia: when should you suspect cancer? Primary Care and Cancer, 1987.

5. Cohen LB, Waye JD. Early removal of polyps in the prevention of colorectal cancer. Internal Medicine for the Specialist 8:55-67, 1987.

6. Cohen LB, Lewis BS. Gastrointestinal hemorrhage. In Gastroenterology for the House Officer (1989). Ed. Sachar DB, Waye JD, Lewis BS. New York: Williams and Wilkins.

7. Rubin PH, Cohen LB. Infectious diarrhea and sexually transmitted diseases of the gastrointestinal tract (including AIDS) (1989). Ed. Sachar DB, Waye JD, Lewis BS, New York: Williams and Wilkins.

8. Cohen LB. A color atlas of colorectal lesions. Primary Care and Cancer, April 1989.

9. Cohen LB. A step-by-step approach to flexible sigmoidoscopy. Primary Care and Cancer, Nov 1989.

10. Cohen LB. Colorectal cancer screening in the elderly. Geriatrics, 1998.

11. Cohen LB. Endoscopic Sedation: Past, Present and Future. Syllabus for Endoscopic Sedation: Preparing for the Future. November 13, 2004.

12. Cohen LB Endoscopic Sedation: Combination Propofol for Endoscopic Sedation. Syllabus for Endoscopic Sedation: Preparing for the Future. November 13, 2004.

13. Cohen LB New Drugs and Delivery Devices for Endoscopic Sedation. Syllabus for Endoscopic Sedation: Preparing for the Future. November 13, 2004.

14. Cohen LB Endoscopic Sedation: Past, Present and Future. Syllabus for Endoscopic Sedation: Preparing for the Future. November 5, 2005.

15. Cohen LB New Drugs and Delivery Devices for Endoscopic Sedation. Syllabus for Endoscopic Sedation: Preparing for the Future. November 5, 2005.

16. Cohen LB New Drugs and Delivery Devices for Endoscopic Sedation. Syllabus for Endoscopic Sedation: Preparing for the Future. November 11, 2006.

16. Cohen LB Training in Endoscopic Sedation and the Role of Simulation. Syllabus for Endoscopic Sedation: Preparing for the Future. November 10, 2007.

17. Cohen LB Patient Monitoring – How, Why and When. Syllabus for Endoscopic Sedation: Preparing for the Future. November 10, 2007.

18. Cohen LB, Tennyson C. Bowel preparation for colonoscopy. Maximizing efficacy, minimizing risk. Gastroenterology and Endoscopy News. October, 2007.

19. Cohen LB. Office-based Endoscopists – Get ready for Office Accreditation! ASGE News, January 2008.

20. Cohen LB. New Bowel Preparations for Colonoscopy. US Gastroenterology Review, 2008.

21. Cohen LB. Understanding Moderate Sedation. ASGE Postgraduate Course, San Diego, May 24, 2008.

22. Cohen LB. New Options for Endoscopic Sedation. US Gastroenterology Review 2008; 4:16-18.

23. Cohen LB. Expert Opinion: Fospropofol Disodium - New Perspectives on Endoscopic Procedures. Reviews in Gastroenterological Disorders 2008;8:213-216.

Books and Chapters:

1. Cohen LB, Waye JD. Treatment of colonic polyps: practical considerations. In Clinics in Gastroenterology (1986). Ed. Classen M, England: W.B. Saunders.

2. Cohen LB, Waye JD. Colonoscopic polypectomy of polyps with adenocarcinoma. In Difficult Problems in Gastroenterology (1988). Ed. Barkin JS, Rogers AI.

3. Cohen, LB, Basuk PB, Waye JD. Practical Flexible Sigmoidoscopy (1995). New York:Igaku-Shoin.

4. Aisenberg J, Cohen LB. Sedation in Endoscopic Practice. Gastrointestinal Endoscopy Clinics of North America. (2006). Philadelphia: Elsevier Saunders.

5. Cohen, LB, Aisenberg J. Sedation for Colonoscopy. In Colonoscopy: Principles and Practice (2009). Ed. Waye, JD, Rex DK, Williams C.

6. Cohen LB, Aisenberg, J. ed. Endoscopic Sedation: Preparing For the Future. Gastrointestinal Endoscopy Clinics of North America. (2008). Philadelphia: Elsevier Saunders.

7. Cohen, LB. Patient Monitoring During Endoscopy – How, When and Why? Gastrointestinal Endoscopy Clinics of North America. (2008). Philadelphia: Elsevier Saunders.

8. Levine A, Cohen LB. Training in Endoscopic Sedation and the Role of Simulation Technology. Gastrointestinal Endoscopy Clinics of North America. (2008). Philadelphia: Elsevier Saunders.

9. Voynarovska, M, Cohen LB. The Role of the Endoscopy Nurse or Assistant in Endoscopic Sedation. Gastrointestinal Endoscopy Clinics of North America. (2008). Philadelphia: Elsevier Saunders.

Invited Lectures / Presentations (since 2003) :

1. “Sedation for Gastrointestinal Endoscopy: Attitudes and Advances” Lenox Hill Hospital, March 12, 2003.

2. “Injectable endoscopic therapies for gastroesophageal reflux” Presented to New York Society for Gastrointestinal Endoscopy. March 4, 2003.

3. “Endoscopic Enteryx Implantation for GERD: A Combined Analysis of the United States and European Experience. World Organization for Specialized Studies on Diseases of the Esophagus”. Sept 3, 2003.

4. “48-hour Wireless pH Monitoring at the Time of Surveillance Endoscopy in Patients with Barrett’s Esophagus. World Organization for Specialized Studies on Diseases of the Esophagus”. Sept 1, 2003.

5. American College of Gastroenterology, Plenary Session Presentation – Enteryx solution, a minimally invasive injectable treatment for GERD: analysis of extended follow-up through 24-months. October 15, 2003.

6. Endoscopic Therapies of GERD. Gastroenterology Grand Rounds. Beth Israel Hospital, New York. October 22, 2003.

7. Endoscopic Therapies of GERD. Gastroenterology Grand Rounds. North Shore University Hospital. New York. December 8, 2003.

8. Major advances in colonoscopic technology: the Colonosight®, a pull-power assisted disposable, non fiber-optic colonoscope. Plenary Session, American Society for Gastrointestinal Endoscopy, New Orleans, LA May 20, 2004

9. Therapy for GERD: Medical, Surgical, or Endoluminal? Gastroenterology Grand Rounds. St Lukes-Roosevelt Hospitals. New York, NY. June 29, 2004.

10. Current Issues in GERD Therapy: Medical, Surgical, Endoscopic? Medical Grand Rounds, Mount Sinai Hospital, New York, NY. August 3, 2004.

11. Therapy for GERD: Medical, Surgical, or Endoluminal? Gastroenterology Grand Rounds. Englewood Hospital, Englewood New Jersey. October 3, 2004.

12. Endoscopic Sedation: Past, Present and Future. Presented at one day symposium: Endoscopic Sedation: Preparing for the Future. November 13, 2004.

13. Endoscopic Sedation: Combination Propofol for Endoscopic Sedation. Presented at one day symposium: Endoscopic Sedation: Preparing for the Future. November 13, 2004.

14. New Drugs and Delivery devices for Endoscopic Sedation. Presented at one day symposium: Endoscopic Sedation: Preparing for the Future. November 13, 2004.

15. Endoscopist-Administered Propofol Sedation: You Don’t Need and Anesthesiologist. The New York Society for Gastrointestinal Endoscopy. Nov 17, 2004.

16. Propofol vs. Standard Sedation. New York Society for Gastrointestinal Endoscopy - The Annual Course. Dec 16, 2004.

17. Endoluminal Therapies for Gastroesophageal reflux Disease: Bake, Stuff or Sew? From Gastroesophageal Reflux Disease to Esophageal Cancer: New Treatments and Technologies. The New York Academy of Medicine. April 2, 2005.

18. The Pros and Cons of Barrett’s Screening. From Gastroesophageal Reflux Disease to Esophageal Cancer: New Treatments and Technologies. The New York Academy of Medicine. April 2, 2005.

19. Endoscopic Sedation: Current Practice, Future Trends. Evening Symposium sponsored by TAP Pharmaceutical. April 19, 2005.

20. GERD: Endoluminal and Surgical Treatment. An Update. Presented at :GERD: Fourth Annual DDW Highlights”. Sponsored by AstraZeneca. June 7, 2005.

21. Endoscopic Sedation: Current Practice, Future Trends. Evening Symposium sponsored by TAP Pharmaceutical. May 23, 2005.

22. Endoscopic Sedation: Current Practice, Future Trends. Gastroenterology Grand Rounds, White Plains Hospital, New York. June 14, 2005

23. Endoluminal GERD Therapies: DDW 2005 Wrap Up. Evening Symposium sponsored by AstraZeneca. June 29, 2005.

24. Who Should Sedate Our Patients: A Gastroenterologists Perspective. New York Society for Gastrointestinal Endoscopy, December 15, 2005.

25. Acid Protection for Chronic NSAID Patients at Risk for Gastric Ulcers. North General Hospital, April 19, 2006.

26. Preparation and Premedication for Colonoscopy. Monmouth Country Gastroenterology Society, April 20, 2006.

27. “Advances in Endoscopic Sedation: is the Right Choice Out There?” Symposium sponsored by MGI Pharma. Digestive Disease Week, May 21, 2006.

28. “Colorectal Cancer Screening: New Directions.” Symposium sponsored by Salix Pharmaceuticals. Digestive Disease Week, May 20, 2006.

29. “Propofol Administration by the Gastroenterologist: Safety and Efficacy in the Ambulatory Setting.” ASGE-Sponsored Symposium “Controversies in Endoscopic Sedation.” May 23, 2006.

30. Non-Medical Therapies of GERD and Extra-Esophageal GERD. DDW Wrap-Up sponsored by AstraZeneca. June 10, 2006.

31. “Increasing Compliance with Colorectal Screening Guidelines.” American College of Gastroenterology Annual Meeting, October 23, 2006.

32. “Endoscopic Sedation: Current Practice, Future Directions.” GI Grand Rounds, Huntingdon Hospital, New York. November 3, 2006.

33.Propofol Administration by the Gastroenterologist: Safety and Efficacy in the Ambulatory Setting. NYSGE-Sponsored Symposium “Controversies in Endoscopy.” November 14, 2006.

34. “Endoscopic Sedation: Current Practice, Future directions.” GI Grand Rounds, Lenox Hill Hospital, New York NY April 19, 2007.

35. Moderator and Presenter. “Evolving Perspectives in Moderate Sedation: Meeting the Challenges.” Symposium at Digestive Disease Week, 2007. May 20, 2007.

36. “Does supplemental oxygen really reduce the risk of cardiopulmonary complications during gastrointestinal endoscopy? Presented at ASGE Topic Forum Minimizing the Risk of Injury to Patients During Endoscopy. Digestive Disease Week, Washington, D.C. May 21, 2007.

37. “Extended Monitoring”. Presented at the ASGE Postgraduate Course, Digestive Disease Week, Washington, DC. May 24, 2007.

38. “Endoscopic Sedation: Past, Present and Future.” Presented at Hellenic Society for Gastroenterology, Crete, Greece. June 30, 2007.

39. “Gastroenterologist-directed administration of propofol” Division of Gastroenterology, Beth Israel Hospital, New York. October 3, 2007.

40. “Laryngo-Pharyngeal Reflux: A Gastroenterologist’s Perspective.” American College of Surgeons, New Orleans. October 9, 2007.

41. “Gastroenterologist-directed Administration of Propofol: Pearls and Pitfalls.” ASGE Advanced Endoscopy Series: Sedation and Monitoring. Oak Brook, IL December 1, 2007.

42. “The Future of Endoscopic Sedation.” ASGE Advanced Endoscopy Series: Sedation and Monitoring. Oak Brook, IL December 1, 2007.

43. “Colonoscopy: Preparation and Premedication.” Methodist Hospital, Brooklyn, New York. January 11, 2008.

44. “Current Issues and Controversies in Endoscopic Sedation.” ACG Board of Governors/ASGE Course – Best Practices 2008. Indian Wells, CA February 1, 2008.

45. “Endoscopic Sedation – A Review”. ACG Regional Course, New York. March 14, 2008.

46. “Strategies to Improve the Outcomes of Colorectal Cancer Screening”. Tufts - New England Medical Center. Gastroenterology Grand Rounds, March 28, 2008.

47. “What Every Endoscopist Should Know about Endoscopic Sedation”. Boston University Medical Center. Endoscopy Grand Rounds. March 28, 2008.

48. “The Practice and Politics of Endoscopic Sedation”. NYU Seminars in Gastroenterology, April 5, 2008.

49. ”State of the Art: Sedation/Analgesia in the Endoscopy Suite.” Gastroenterology Practice and Endoscopic ASCs 2008 – Challenges and Opportunities. Knoxville, TN. April 11, 2008.

50. “Understanding Moderate Sedation”. ASGE Postgraduate Course, San Diego, CA May 23, 2008.

51. “Endoscopic Sedation: Where Do We Go from Here?” ASGE Endoscopy Directors Special Interest Group. San Diego, CA May 21, 2008.

52. “The Science and Politics of Endoscopic Sedation.” ASGE Ambulatory Endoscopy Center Special Interest Group. San Diego, CA May 22, 2008.

53. “Endoscopic Sedation” (multiple lectures). Sedation and Monitoring Course (ASGE sponsored). Oak Brook, IL. June 13-14, 2008.

54. “The Difficult-to-Sedate Patient”. ACG Regional Postgraduate Course, Williamsburg, VA. Sept 5, 2008.

55. “Recent Advances in Endoscopic Sedation”. Florida Gastroenterologic Society - 43rd Annual Meeting. Naples, FL. Sept 7, 2008.

56. “Advances in Technology for Sedation”. New York Society for Gastrointestinal Endoscopy, New York, NY. October 21, 2008.

57. “Endoscopic Sedation: Current Practice, Future Trends.” Jefferson Medical College, Gastroenterology Division Grand Rounds, Philadelphia, PA December 3, 2008.

58. “Endoscopic Sedation: Problems and Prospects.” New York Society for Gastrointestinal Endoscopy, New York, NY. December 19, 2008.

59. “The Challenges of Current techniques of Endoscopic Sedation.” Practice Management Seminar, The New York Society for Gastrointestinal Endoscopy, New York. December 20, 2008.

60. “Endoscopic Sedation: Problems, Politics and Prospects” Gastroenterology Grand Rounds, Westchester Medical Center, Valhalla, New York January 21, 2009.

61. “Endoscopic Sedation in the United States” The 24th Annual Conference on Anesthesiology. San Juan, PR. January 22, 2009.

62. “Improving the Outcomes of Screening Colonoscopy” The Mississippi State Gastroenterology Society Annual Meeting, Jackson, MS. February 7, 2009.

63. “Improving the Outcomes of Screening Colonoscopy” North Shore Medical Center. Gastroenterology Grand Rounds, New York, NY. February 9, 2009.

64. “Endoscopic Sedation: Problems, Prospects, and Politics” Delaware Valley Society for Gastrointestinal Endoscopy. Philadelphia, PA. February 11, 2009.

65. “Endoscopic sedation: A National Perspective” ACG Regional Meeting, New York. March 13, 2009.

66. “The Bottom Line: How to Sedate Patients” ACG Regional Meeting, New York. March 13, 2009.

67. “The Perils of Production Pressure” ASGE Special Symposium, Digestive Disease Week, Chicago, IL. June 2, 2009.

68. “Issues in Endoscopic Sedation”. Meet the Professor Lunch, Digestive Disease Week. Chicago, IL. June 2, 2009.

Media Resource Educational Materials:

1. Interactive case presentations – used for exhibition and training of gastroenterologists. Waye, JD and Cohen LB. Prepared for Merck, Inc. 1985-1986.

2. Training video demonstrating techniques of flexible sigmoidoscopy. Produced by Igaku- Shoin. 1990.

3. Teaching video demonstrating techniques of Endoscopic injection of Enteryx. Prepared for Boston Scientific. 2004-2005.

4. Enteryx Training Session : A Webcast. March 24, 2005.

5. Training Video on Gastroesophageal Reflux Disease. TAP Pharmaceuticals. June, 2006.

Abstracts:

1. Cohen LB, Wolke A, Field SM, et al. The role of plasmapheresis in primary biliary cirrhosis. Gastroenterology 1983;84:1126.

2. Cohen LB, Meyers S, et al. Cryoproteins in inflammatory bowel disease. Gastroenterology 1983;84:1126.

3. Simon C, Cohen LB, et al. Esophageal motility and symptoms after endoscopic injection sclerotherapy. Gastrointestinal Endoscopy 1983;29:192.

4. Rubenstein AE, Cohen LB, Aron AM, Wallace S. Primary mesenteric plexus alterations as a cause of megacolon in neurofibromatosis. Neurology 1984;34:214 (Suppl 1).

5. Cohen LB, Harpaz, N, Sicular A, Friedman G. The nutcracker esophagus: a clinical, radiographic, manometric and histopathologic case study. Am J Gastroenterology, 1992;87: 1353.

6. Cohen LB, Salky BA, Edye M. Laparoscopic nissen fundoplication: an effective anti-reflux procedure. Preliminary report. International Organization for Statistical Studies on Diseases of the Esophagus. Fourth International Congress, Paris, France 1993.

7. Johnson DA, Aisenberg J, Cohen LB, et al. Enteryx solution, a minimally invasive injectable treatment for GERD: initial multicenter human trial results. Am J Gastroenterol 2001;96:S17.

8. Lehman G, Aisenberg J, Cohen L, et al. Enteryx solution, a minimally invasive injectable treatment for GERD: international trial results. Gastroenterology 2002;122:AB101.

9. Lehman G, Aisenberg J, Cohen L, et al. Improvement in esophageal pH probe studies after Enteryx therapy for GERD. Gastroenterology 2002;122:AB89.

10. Johnson DA, Aisenberg J, Cohen L, et al. Enteryx, an injectable treatment for GERD: Multicenter results. Am J Gastroenterol 2002;97:S12.

11. Aisenberg, A, Cohen LB, Foley TR, Ganz R, Johnson DA. Enteryx Solution, A Minimally Invasive Injectable Treatment For GERD: The Private Practice Experience. Gastrointest Endosc 2003;57: M1738.

12. Cohen LB, Dubovsky, AM, Aisenberg, J, Miller KM. Propofol for Endoscopic Sedation: A Protocol for Safe and Effective Administration by the Gastroenterologist. Gastrointest Endosc 2003;57: S1475.

13. Ganz R, Aisenberg J, Cohen LB, Deviere J, Foley TR, Haber G, et.al. Enteryx Solution, A minimally invasive injectable treatment for GERD: Analysis of endoscopy findings at 12 months. Gastrointest Endosc 2003;57: M1743.

14. Johnson DA, Aisenberg J, Cohen LB, Deviere J, Foley TR, Ganz R, Haber G, Lehman GA, Peters JH. Enteryx Solution, A Minimally Invasive Injectable Treatment for GERD: Analysis of X-Ray Findings Over 12 Months. Gastrointest Endosc 2003;57: M1730.

15. Lehman GA, Hieston KJ, Aisenberg J, Cohen LB, Miller KM, Dsouza C, et. al. Enteryx Solution, a Minimally Invasive Injectable Treatment for GERD: Current Worldwide Multi-center Human Trial Results. Gastrointest Endosc 2003;57:672.

16. Lehman GA, Hieston KJ, Johnson DA, Stacy TL, Aisenberg, J, Cohen LB, et al. Enteryx solution, a minimally invasive injectable treatment for GERD: Analysis of pH-metry and manometry findings over 12 months. Gastrointest Endosc 2003;57: M1734.

17. Cohen LB, Johnson JA, Aisenberg J, Foley TR, Ganz R, Lehman G. Enteryx solution, a minimally invasive injectable treatment for GERD: analysis of extended follow-up through 24-months. Am J Gastroenterol 2003;98:71.

18. Shike M, Repici A, Cohen LB, Goldfarb-Albak S, Fireman Z. Major advances in colonoscopic technology: the Colonosight®, a pull-power assisted disposable, non fiber-optic colonoscope. Gastrointestinal Endoscopy 2004;59:AB113.

19. Cohen LB, Hightower CD, Wood DA, Miller KM, Aisenberg J. Moderate-Level sedation during endoscopy using low-dose propofol, midazolam and an opioid. Gastrointest Endosc 2004;59:AB127.

20. Lehman GA, Hieston K, Cohen LB, D’Souza C, Aisenberg J, Ganz R, et. al. Correlation between clinical outcome and Enteryx implant shape. Gastrointest Endosc 2004;59:AB149.

21. Deviere J, Cohen LB, Aisenberg J, Ganz R, Lehman GA, Foley TR, et. al. Predictors of Enteryx outcomes at 12 months. Gastrointest Endosc 2004;59:AB243.

22. Johnson DA, Aisenberg J, Cohen LB, Ganz R, Lehman GA, Foley TR et. al. Clinical benefits of Enteryx for high-dose PPI-patients. Gastrointest Endosc 2004;59:AB245.

23. Cohen LB, Hightower CD, Wood DA, Wecsler J, Gaetano JN, Miller KM, et.al.
Wireless pH-metry Combined with Surveillance Endoscopy in Barrett’s Esophagus. Am J Gastroenterol 2004;99:35.

24. Cohen LB, Dubovsky A, Gaetano JN, Wecsler J, Miller KM, Aisenberg J. Endoscopic sedation: a survey of patient attitudes and expectations during colonoscopy. Am J Gastroenterol 2004;99:908.

25. Cohen LB, Aisenberg J, Foley TR, Ganz RA, Johnson DA, Lehman G, et al. Enteryx®: Worldwide pivotal studies in 237 patients. Am J Gastroenterol 99:897, 2004.

26. Johnson DA, Aisenberg J, Cohen LB, Foley TR, Ganz RA, Lehman G. Durability and long-term safety of enteryx implantation for GERD: 24-Month Follow-Up of a Prospective Multicenter Trial. Am J Gastroenterol 99:904, 2004.

27. Pruitt RE, Cohen LB, Gibjansky E, Wang C, Strayhorn S, Weinstein M, et. al. Sedation with AQUAVAN injection during colonoscopy: a randomized, open-label, multicenter, adaptive dose-ranging phase II study of safety and efficacy.

28. Fockens P, Edmundowicz S, Cohen LB, Rothstein R, Nickl NN, Overholt B, et.al. Gatekeeper Therapy: An endoscopic treatment for GERD: Randomized, Sham-controlled Multi-center Trial Overview. DDW, 2005.

29. Pruitt RE, Cohen LB, Gibiansky E, Wang C, Strayhorn S, Weinstein M, et.al. A Randomized, Open-label, Multicenter, Dose-Ranging Study of Sedation with AQUAVAN Injection (GPI 15715) during Colonoscopy. DDW, 2005.

30. Cohen LB, Manzi DJ, Rex DK, Moses PL, Adams DC. Bispectral Index-guided (BIS) Administration of Propofol for Endoscopic Sedation: A Prospective, Randomized, Multi-center Study. DDW, 2005.

31. Cohen LB, Manzi DJ, Rex DK, Moses PL, Adams DC. Bispectral Index (BIS) Correlates Well with American Society for Anesthesiology (ASA) Sedation Levels during Colonoscopy Performed With Propofol Sedation. DDW, 2005.

32. Cohen LB, Wecsler JS, Gaetano JN, Durkalski V, Miller KM, Aisenberg J. Endoscopic Sedation in the United States in 2004: Results from a Postal Survey of 5000 Gastroenterologists. DDW, 2005.

33. Cohen LB, Weitman ES, Voynarovska M, Miller KM, Aisenberg J. Gastroenterologist-Directed Propofol, Midazolam and Fentanyl for Endoscopic Sedation: Adverse Events During 4,213 Procedures. DDW, 2005.

34. Lehman GA, Aisenberg J, Cohen LB, Foley TR, Ganz RA, Johnson DA. Endoscopic Implantation of Enteryx® for the Treatment of GERD: 36-Month Follow-Up in 46 Subjects. DDW, 2005.

35. Lehman GA, Chen Y, Mendolia T, Cohen LB, Deviere J, Foley TR, et. al. Improved Acid Control and Symptom Scores 3 Months Post-Enteryx: Initial US Randomized Control Trial Results. DDW, 2005.

36. Cohen LB, Akhavan A, Benson A, Bodian C, Miller KM, Aisenberg J. Propofol versus Propofol-Meperidine-Midazolam for Upper Endoscopy: A Cross-over Study Comparing Parameters of Sedation and Recovery. DDW, 2006.

37. Cohen LB, Waye JD, Benson A, Akhavan A, Bodian C, Miller KM, Aisenberg J. Sedation Practices Worldwide: Results from an International Survey of Expert Endoscopists. DDW, 2006.

38. Cohen LB, Wang Chao, Jones JB. A randomized, double-blind, dose-response study to assess the efficacy and safety of fospropofol disodium for minimal to moderate sedation during colonoscopy. DDW, 2006.

39. Cohen LB, Popp J, Kodali V. Efficacy and Safety of a New Sodium Phosphate Tablet Bowel Purgative Versus a 2-L Polyethylene Glycol Electrolyte Lavage Solution Plus Bisacodyl Tablets. Am J Gastroenterol 2006;101:S555.

40. Cohen LB, Kastenberg D, Lottes SR, Forbes WP, Carter E. Polyp Detection Rate During Colonoscopy is Correlated With Quality of Bowel Preparation. Am J Gastroenterol 2006;101:S556.

41. Cohen LB, Wang C, Jones, JB. Physician and patient satisfaction for AQUAVAN® in a randomized, double-blind, multicenter, dose-finding colonoscopy study. Am J Gastroenterol 2006;101:S514.

42. Cohen LB, Kline J, Wang C, Jones JB. AQUAVAN® for moderate sedation during colonoscopy: Results of a phase 2, multicenter, randomized, dose-response study. Am J Gastroenterol 2006;101:S515.

43. Cohen LB, Holub JL, Lieberman DA, Desai J. Aisenberg J. Does Routine Use of Supplemental Oxygen During Endoscopy Really Reduce the Risk of Cardiopulmonary Complications? Gastrointest Endosc 2007;65:AB103.

44. Rex DK, Cohen LC, Kline J, Wang C. Fospropofol disodium is effective and safe for minimal to moderate sedation in patients undergoing colonoscopy: Results of a phase 3, randomized, double-blind, trial. Gastrointest Endosc 2007;65:AB369.

45. Rex DK, Cohen LC, Kline J, Wang C. Fospropofol disodium for minimal-to-moderate sedation during colonoscopy produces clear-headed recovery: Results of a phase 3, randomized, double-blind trial. Gastrointest Endosc 2007;65:AB367.

46. Cohen LC, Rex DK, Kline J, Wang C. Patient and Physician satisfaction with fospropofol disodium: Results of a phase 3, randomized, double-blind trial evaluating fospropofol disodium for moderate sedation in patients undergoing colonoscopy. Gastrointest Endosc 2007;65:AB367.

47. Deenadayalu, VP, Rex, DK, Eid E, Goff J, Walker J, Cohen LB, et.al. Non-anesthesiologist Administered Propofol Sedation for Endoscopic Procedures: A Worldwide Safety Review. Gastrointest Endosc 2008. Gastrointest Endosc 2008;67:AB107.

48. Dikman A, Sanyal S, Aisenberg J, Miller KM, Cohen LB. Gastroenterologist-Directed, Balanced Propofol Sedation for EGD and Colonoscopy: an Analysis of Safety in 15,286 Patients. Gastrointest Endosc 2008;67:AB84.

49. Dikman A, Sanyal S, von Althann C, Whitson MJ, Desai J, Bamji N, Cohen LB, Miller KM, and Aisenberg J. Is Endoscopic Biopsy Safe in Patients receiving Anti-Platelet Agents? DDW, 2009.

NYGA Home

Our Services

Meet Our Physicians

GI Conditions

Contact Us

© New York Gastroenterology Associates, L.L.P
NYGA 311 E. 79th Street, Suite 2A NY, NY 10075 212.996.6633
Privacy & Terms of Use | Why Choose NYGA | Colonoscopy | Capsule Endoscopy | Endoscopy | Patient GI Conditions
GI Services & Treatments Colon Cancer & Polyps | ERCP | Breath Testing | Flexible Sigmoidoscopy | Our Gastroenterologists
Gastroenterology Website Design | Medical Website Design | Medical Website Marketing by Vital Element, Inc.